Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Co-Occurring Opioid and Amphetamine Dependence
NCT02541526Phase 3Unknown
- Sponsor
- Universiti Sains Malaysia
- Start
- May 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in amphetamine dependence comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Reduction of illicit ATS use at 18 weeks. Status: unknown.
02
Drugs
mirtazapine
03
Conditions
amphetamine dependence
Beyond the preview
Go deeper on NCT02541526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541526.